They say if something looks too good to be true, it probably is. So, be patient with OPK. It will have its ups and downs, but three years from now, those who hold and accumulate will probably be rolling in dough...unless its too good to be true.
Too good to be true could be appropriately applied to many companies, many stocks. But here's a point to be reckoned. OPK just sold $175M of notes mostly to investors that we will never know by name. Frost and Hsiao bought just a small portion...about $8,250M of the 175. That leaves 166.75M bucks snapped up in 3 days by people who apparently believed that 7.07 a share is a bargain price for a common share.
Hard as it might be for most, one needs to THINK for ones self.
I think we will be 'rolling in dough' a lot sooner than 3 years from now. Frost is definitely working at a much more diligent and swift pace than he has in the past with the first 2 companies he built & sold. As you know, he is now 75 years old. And just in the past year or so he has partnered with Brystol Meyers, acquired a Claros Diagnostics, acquired an Isreali Pharma company, acquired a lab in Tennessee w national locations, acquired a Spanish pharma company, acquired a Brazilian pharma co,.. the list goes on.. and he has also just completed a financing of $175M which will only escalate the buying spree that Frost has been on. And Frost was already quoted saying ..'there is more value in OPKO than any other company he has ever worked with..' So again, I think our timeline for big gains is a lot sooner than 3 years.